Hofseth Biocare ASA
OSE:HBC

Watchlist Manager
Hofseth Biocare ASA Logo
Hofseth Biocare ASA
OSE:HBC
Watchlist
Price: 1.43 NOK Market Closed
Market Cap: 565m NOK
Have any thoughts about
Hofseth Biocare ASA?
Write Note

Hofseth Biocare ASA
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hofseth Biocare ASA
Revenue Peer Comparison

Comparables:
B
BGBIO
L
LYTIX
AZT
N
NYKD
T
TRMED

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Hofseth Biocare ASA
OSE:HBC
Revenue
kr221.9m
CAGR 3-Years
41%
CAGR 5-Years
30%
CAGR 10-Years
14%
B
Bergenbio ASA
OSE:BGBIO
Revenue
kr521k
CAGR 3-Years
-5%
CAGR 5-Years
-46%
CAGR 10-Years
N/A
L
Lytix Biopharma AS
OSE:LYTIX
Revenue
kr4m
CAGR 3-Years
N/A
CAGR 5-Years
64%
CAGR 10-Years
N/A
Arcticzymes Technologies ASA
OSE:AZT
Revenue
kr116m
CAGR 3-Years
4%
CAGR 5-Years
10%
CAGR 10-Years
17%
N
Nykode Therapeutics ASA
OSE:NYKD
Revenue
$6.1m
CAGR 3-Years
-70%
CAGR 5-Years
229%
CAGR 10-Years
N/A
T
Thor Medical ASA
OSE:TRMED
Revenue
kr0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Hofseth Biocare ASA's Revenue?
Revenue
221.9m NOK

Based on the financial report for Jun 30, 2024, Hofseth Biocare ASA's Revenue amounts to 221.9m NOK.

What is Hofseth Biocare ASA's Revenue growth rate?
Revenue CAGR 10Y
14%

Over the last year, the Revenue growth was 20%. The average annual Revenue growth rates for Hofseth Biocare ASA have been 41% over the past three years , 30% over the past five years , and 14% over the past ten years .

Back to Top